189 related articles for article (PubMed ID: 17292047)
1. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.
Heydemann A; McNally EM
Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047
[TBL] [Abstract][Full Text] [Related]
2. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
3. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.
Lapidos KA; Kakkar R; McNally EM
Circ Res; 2004 Apr; 94(8):1023-31. PubMed ID: 15117830
[TBL] [Abstract][Full Text] [Related]
4. Localization of sarcoglycan, neuronal nitric oxide synthase, beta-dystroglycan, and dystrophin molecules in normal skeletal myofiber: triple immunogold labeling electron microscopy.
Wakayama Y; Inoue M; Kojima H; Murahashi M; Shibuya S; Oniki H
Microsc Res Tech; 2001 Nov; 55(3):154-63. PubMed ID: 11747090
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
Judge LM; Haraguchiln M; Chamberlain JS
J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
[TBL] [Abstract][Full Text] [Related]
6. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.
Hack AA; Lam MY; Cordier L; Shoturma DI; Ly CT; Hadhazy MA; Hadhazy MR; Sweeney HL; McNally EM
J Cell Sci; 2000 Jul; 113 ( Pt 14)():2535-44. PubMed ID: 10862711
[TBL] [Abstract][Full Text] [Related]
7. Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants.
Allikian MJ; Bhabha G; Dospoy P; Heydemann A; Ryder P; Earley JU; Wolf MJ; Rockman HA; McNally EM
Hum Mol Genet; 2007 Dec; 16(23):2933-43. PubMed ID: 17855453
[TBL] [Abstract][Full Text] [Related]
8. Processing and assembly of the dystrophin glycoprotein complex.
Allikian MJ; McNally EM
Traffic; 2007 Mar; 8(3):177-83. PubMed ID: 17274800
[TBL] [Abstract][Full Text] [Related]
9. Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting.
Chen J; Shi W; Zhang Y; Sokol R; Cai H; Lun M; Moore BF; Farber MJ; Stepanchick JS; Bönnemann CG; Chan YM
Exp Cell Res; 2006 May; 312(9):1610-25. PubMed ID: 16524571
[TBL] [Abstract][Full Text] [Related]
10. Functional nitric oxide synthase mislocalization in cardiomyopathy.
Heydemann A; Huber JM; Kakkar R; Wheeler MT; McNally EM
J Mol Cell Cardiol; 2004 Feb; 36(2):213-23. PubMed ID: 14871549
[TBL] [Abstract][Full Text] [Related]
11. Sarcoglycan subcomplex in normal human smooth muscle: an immunohistochemical and molecular study.
Anastasi G; Cutroneo G; Sidoti A; Santoro G; D'Angelo R; Rizzo G; Rinaldi C; Giacobbe O; Bramanti P; Navarra G; Amato A; Favaloro A
Int J Mol Med; 2005 Sep; 16(3):367-74. PubMed ID: 16077941
[TBL] [Abstract][Full Text] [Related]
12. Sarcoglycan subcomplex in normal and pathological human muscle fibers.
Anastasi G; Cutroneo G; Rizzo G; Favaloro A
Eur J Histochem; 2007; 51 Suppl 1():29-33. PubMed ID: 17703591
[TBL] [Abstract][Full Text] [Related]
13. Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle.
Allikian MJ; Hack AA; Mewborn S; Mayer U; McNally EM
J Cell Sci; 2004 Aug; 117(Pt 17):3821-30. PubMed ID: 15252120
[TBL] [Abstract][Full Text] [Related]
14. Biology of the striated muscle dystrophin-glycoprotein complex.
Ervasti JM; Sonnemann KJ
Int Rev Cytol; 2008; 265():191-225. PubMed ID: 18275889
[TBL] [Abstract][Full Text] [Related]
15. Remodeling of dystrophin and sarcomeric Z-band occurs in pediatric cardiomyopathies: a unifying mechanism for force transmission defect.
Vatta M; Sinagra G; Brunelli L; Faulkner G
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):149-56. PubMed ID: 19194174
[TBL] [Abstract][Full Text] [Related]
16. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
[TBL] [Abstract][Full Text] [Related]
17. Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?
Towbin JA; Bowles NE
J Clin Invest; 2001 Jan; 107(2):153-4. PubMed ID: 11160128
[No Abstract] [Full Text] [Related]
18. Novel γ-sarcoglycan-mutation affects cardiac function and N-terminal dystrophin expression.
Schröder NW; Grieben U; Prokop S; Dekomien G; Epplen JT; Heppner FL; Goebel HH; Stenzel W
Muscle Nerve; 2014 Jan; 49(1):144-5. PubMed ID: 23929688
[No Abstract] [Full Text] [Related]
19. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.
Cohn RD; Durbeej M; Moore SA; Coral-Vazquez R; Prouty S; Campbell KP
J Clin Invest; 2001 Jan; 107(2):R1-7. PubMed ID: 11160141
[TBL] [Abstract][Full Text] [Related]
20. Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy.
Batchelor CL; Winder SJ
Trends Cell Biol; 2006 Apr; 16(4):198-205. PubMed ID: 16515861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
